Buscar
Congreso SOLACI
Home Tags Tricuspid regurgitation

Tag: tricuspid regurgitation

TRAVEL Trial One-Year Outcomes: Transcatheter Treatment of the Tricuspid Valve

Dr. Andrés Rodríguez - 0

Tricuspid Regurgitation, TriBicaval Registry

Dr. Carlos Fava - 0

Heterotopic Treatment of the Tricuspid Valve

Dr. Carlos Fava - 0

Transcatheter Tricuspid Valve Replacement: 1-Year Outcomes

Dr. Andrés Rodríguez - 0

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Dr. Carlos Fava - 0
Sobrevida en pacientes con insuficiencia tricuspídea según variables clínicas y ecocardiográficas (Clusters)

Percutaneous Treatment of Tricuspid Regurgitation with K-CLIP

Dr. Carlos Fava - 0

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

Dr. Omar Tupayachi - 0

TRI-SPA Study: Tricuspid Edge-to-Edge Treatment

Dr. Carlos Fava - 0

Edge-to-Edge Repair for Right Ventricular Function Deterioration

solaci - 0
valvula tricuspide

TricValve: 12-Month Evolution

solaci - 0
12Page 1 of 2

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Dr. Juan Manuel Pérez - 0
Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Dr. Juan Manuel Pérez - 0
Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Dr. Omar Tupayachi - 0
Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

Noticias Institucionales

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

SOL SOLACI performed a new procedure in Argentina using bioabsorbable stents in pulmonary branches

solaci - 0
The SOLACI Solidarity Program carried out a new procedure on a patient from the region of Frías, in Santiago del Estero (Argentina), during October...

Venezuela 2025 Sessions | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submissions LIII SOLACI Regional Sessions – 18th Andean Region We invite all young Latin American cardiologists to submit clinically relevant interventional cardiology cases...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad